NCT05278676View on ClinicalTrials.gov

A Single and Multiple Dose Study of Dotinurad in Chinese Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 13, 2022

Study Completion Date

December 13, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Dotinurad

Dotinurad oral tablet.

Trial Locations (1)

Unknown

Shanghai Xuhui District Central Hospital, Shanghai

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY